Armistice Capital, LLC Gt Biopharma, Inc. Transaction History

Armistice Capital, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	SELL	$0.46 - $1.05 $547,390 - $1.25 Million	-1,189,980 Reduced 35.1%	2,200,020 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$0.89 - $58.2 $3.02 Million - $197 Million	3,390,000 New	3,390,000 $3.02 Million

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $81.7M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.